If you need more lookups,
subscriptions start at $34 USD/month.
Mark de Souza Location
Berkeley, CA, US
Mark de Souza Work
2022 -now President and CEO @
2016 -2025 Co-Founder, President @ Willow Neuroscience
2019 -2024 Co-Founder and Executive Chairman @
2021 -2024 Co-Founder, Board member @ Phoenicis Therapeutics
2014 -2022 Co-Founder and Board Member @ NFlection Therapeutics, Inc.
2019 -2021 COO and CFO @
2015 -2021 Co-Founder, President and CEO @ Chromaderm Inc (merged with Dermbiont, Inc.)
2018 -2021 Co-Founder, President and CEO @ FIBRX Derm, Inc. (merged into Phoenicis Therapeutics)
2018 -2020 Co-Founder and Chief Executive Officer @ SeylanMED, LLC (merged with Dermbiont)
2015 -2017 Executive Chairman @ PellePharm, a BridgeBio company
2013 -2014 Consultant @
2011 -2013 Co-Founder, President and CEO @ Lotus Tissue Repair, Inc. (acquired by Shire)
2001 -2011 Vice President, Business Development @ Dyax Corp. (acquired by Shire)
Mark de Souza Skills
Program Management
Biotechnology
Management
Sales
Business Analysis
Mark de Souza Summary
Mark de Souza, based in Berkeley, CA, US, is currently a President and CEO at SonALAsense. Mark de Souza brings experience from previous roles at Willow Neuroscience, Flightpath Biosciences, Inc, Phoenicis Therapeutics and NFlection Therapeutics, Inc.. With a robust skill set that includes Program Management, Biotechnology, Management, Sales, Business Analysis and more. Mark de Souza has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark de Souza?
Find contact details for 700 million professionals.